EUVIMEDEUVIMED entdecken
Evaluationsstudie

Dual-mode colorimetric-SPR immunosensor based on gold nanoparticles for sCD146 detection in plasma

Zhaochen Huo, Qilong Li, Miaomiao Liu, Xiaofei Xing, Xiangheng Fan, Yilin Wang

Biosensors and Bioelectronics · 2025

DOI: 10.1016/j.bios.2025.117702 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Zhaochen Huo und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Electrical and Information Engineering, Zhengzhou University, Henan, Zhengzhou, 450001, China. Hauptthemen laut MEDLINE: Gold, Colorimetry, Surface Plasmon Resonance, Metal Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Soluble cluster of differentiation 146 (sCD146) is expressed in various immune cells and plays crucial roles in cellular processes linked to tumor cell metastasis, as well as in cell signalling, migration, proliferation, and inflammation. Detecting sCD146 in plasma has become a promising approach for early cancer screening. A rapid and highly specific dual-mode immunosensor that integrates colorimetry and surface plasmon resonance (SPR) techniques was successfully developed in this study. Specifically, bovine serum albumin (BSA)-modified gold nanoparticles (AuNPs) with exceptional peroxidase (POD) activity and SPR properties were synthesized. Under optimum conditions, the linear range of the immunosensors for sCD146 detection was 5-600 ng/mL. The detection limits (LODs) were 4 ng/mL (colorimetric) and 1 ng/mL (SPR). In addition, the results of this colorimetric and SPR dual-mode immunosensor were essentially consistent with those of the conventional ELISA method (P > 0.05). This dual-mode immunosensor based on AuNPs not only has significant potential for detecting sCD146 in plasma but also offers a versatile and efficient platform for blood biomarker analysis. This novel technology opens new avenues for diagnosing cancer and predicting cancer prognosis, thereby having substantial implications for both scientific research and clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldColorimetrySurface Plasmon ResonanceMetal NanoparticlesBiosensing TechniquesCD146 AntigenBiomarkers, TumorHumansLimit of DetectionImmunoassaySerum Albumin, BovineAntibodies, ImmobilizedAnimals

Stichwörter der Autor:innen

AuNPsColorimetric detectionDual-mode biosensorSurface plasmon resonancesCD146

Substanzen

GoldCD146 AntigenSerum Albumin, BovineAntibodies, ImmobilizedBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Electrical and Information Engineering, Zhengzhou University, Henan, Zhengzhou, 450001, China.
  • College of Public Health, Zhengzhou University, Henan, Zhengzhou, 450001, China.
  • College of Public Health, Zhengzhou University, Henan, Zhengzhou, 450001, China. Electronic address: yilinwang90@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huo, Z., Li, Q., Liu, M., Xing, X., Fan, X., & Wang, Y. (2025). Dual-mode colorimetric-SPR immunosensor based on gold nanoparticles for sCD146 detection in plasma. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117702

Vancouver

Huo Z, Li Q, Liu M, Xing X, Fan X, Wang Y. Dual-mode colorimetric-SPR immunosensor based on gold nanoparticles for sCD146 detection in plasma. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117702

BibTeX
@article{Huo2025,
  author = {Huo, Zhaochen and Li, Qilong and Liu, Miaomiao and Xing, Xiaofei and Fan, Xiangheng and Wang, Yilin},
  title = {Dual-mode colorimetric-SPR immunosensor based on gold nanoparticles for sCD146 detection in plasma},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  doi = {10.1016/j.bios.2025.117702}
}
Kostenlos starten →